Aehr Test Systems (AEHR) Stock Forecast and Price Target (2026)
Last updated November 2026
Short answer
4 analysts covering Aehr Test Systems (AEHR) carry an average price target of $123.75 as of November 2026, +142.7% against the $50.98 share price on November 16, 2026. The published targets run from $110.00 to $140.00, a spread of 24% of the average, so the disagreement is narrow. The rating split is 5 buy, 0 hold, 0 sell. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market. Walnut is not an investment adviser.
AEHR analyst price targets
AEHR analyst data as of November 2026, sourced from Yahoo Finance and may be delayed. The price is the last one Yahoo Finance reported on November 16, 2026.A price target is what an analyst published on a date, not a forecast Walnut endorses, and targets are typically set on a 12-month view. Verify current figures before deciding.
The average target of $123.75 sits well above the $50.98 price, +142.7%. The median is $122.50, and where the two differ the median is the steadier read, because one unusually high or low target cannot drag it.
What the AEHR target range actually tells you
The published targets span $110.00 to $140.00. That gap is 24% of the average target, which counts as narrow disagreement. A spread that tight means the analysts broadly agree on the model, so the consensus is a reasonably stable read of a shared view.
The useful move is to read the high target as one bull scenario and the low target as one bear scenario, then ask which set of assumptions you find more plausible. Both cases are worked through on the AEHR is it a buy page.
Recent analyst actions on AEHR
| Firm | Action | Target | Prior | Date |
|---|---|---|---|---|
| Lake Street | Lowered (Buy) | $90.00 | $110.00 | November 3, 2026 |
| Jefferies | Lowered (Buy) | $140.00 | $175.00 | November 3, 2026 |
| Oppenheimer | Initiated (Outperform) | $120.00 | - | September 10, 2026 |
| Jefferies | Initiated (Buy) | $175.00 | - | August 14, 2026 |
The most recent published rating actions on AEHR within the last six months, from Yahoo Finance. Each row is dated because a target only means something alongside the date it was set. Walnut is not an investment adviser and does not endorse any of these views.
In the last six months there have been 0 raises and 2 cuts among these actions. The direction of revisions is often more telling than the level, because it shows which way informed opinion is moving.
How analysts rate AEHR
Of the analysts with a published rating, 5 say buy, 0 say hold, and 0 say sell, so 100% carry a buy. That mix has been broadly steady over the last three months.
The distribution says more than the label. Sell ratings are rare across the entire market for structural reasons, so a stock with no sell ratings is unremarkable, while even a handful of them is worth understanding.
Why a AEHR price target is not a prediction
- It is a 12-month model output. An analyst picks assumptions for revenue, margin, and a multiple, and the target falls out of the arithmetic. Change one assumption and the target moves a lot.
- The distribution is skewed. Sell-side coverage carries far more buy ratings than sell ratings across the whole market, so the average is not a balanced vote.
- Targets follow price as often as they lead it. Revisions frequently arrive after a move, not before, which is why a rising target is weak evidence on its own.
- Nobody is scored on it. There is no cost to a target that never gets close, so treat accuracy as unverified unless you check the firm's record yourself.
AEHR earnings and revenue forecast
For the fiscal year ending Jun 2027, the 5 analysts publishing estimates on AEHR expect earnings of $1.00 per share (+3227% on the year before) and revenue of $150.5 million (+201%).
| Period | EPS estimate | EPS growth | Revenue estimate | Revenue growth |
|---|---|---|---|---|
Quarter ending Sep 2026 next quarter to report, 3 analysts | $0.13 $0.12 to $0.13 | +1167% | $27.5 million $27.2 million to $27.9 million | +151% |
Quarter ending Mar 2027 the quarter after, 5 analysts | $0.24 $0.20 to $0.32 | n/a | $39.4 million $38.7 million to $40.4 million | +282% |
Fiscal year ending Jun 2027 fiscal year next to report, 5 analysts | $1.00 $0.90 to $1.23 | +3227% | $150.5 million $150 million to $151.6 million | +201% |
Fiscal year ending Jun 2028 the fiscal year after, 4 analysts | $1.68 $1.44 to $2.08 | +69% | $229.9 million $200 million to $280.2 million | +53% |
Consensus estimates for AEHR published by sell-side analysts, as of November 2026, from Yahoo Finance. Each figure is the average of the analysts counted, with the lowest and highest estimate beneath it; growth compares with the same period a year earlier and is left blank where either figure is a loss. Estimates change constantly. Walnut is not an investment adviser.
Estimates are the most widely published forecast there is: many more analysts model a company's earnings than publish a price target on it. They are also revised constantly, and the direction of those revisions into a report is often more informative than the level. Aehr Test Systems next reports on November 2, 2026, which is when these figures get tested against actual results.
Is there a 2030 forecast for AEHR?
Not a published one. Analyst price targets run to about twelve months, occasionally two years, and the firms covering AEHR do not put out a 2030 number. Anything presenting one is extrapolating a growth rate of its own, and a figure produced that way tells you about the assumption chosen, not about the company.
The furthest-out consensus that exists is for the fiscal year ending Jun 2028: analysts expect earnings of $1.68 per share, +69% on the fiscal year ending Jun 2027 estimate of $1.00. Beyond that, nobody publishes estimates, so any later number is an extrapolation.
What can be said over a long horizon is what the current price already assumes about the business, which is a question the filings answer and a forecast cannot.
For a ten-year question, that frame is more useful. A share price is the market’s estimate of future cash flows discounted to today, so the multiple is already a statement about growth. The long-horizon question is whether Aehr Test Systems can deliver what is priced in, and what would have to change for that to break. Both are answerable from the drivers and risks below. A number for 2030 is not.
What could move AEHR from here
In short: the drivers cited most often are AI and data center diversification, Silicon photonics and optical interconnect, New device markets: GaN. The risk cited most often against it is customer concentration is heavy: a small number of large semiconductor manufacturers drive most revenue, and the AI story leans on one lead hyperscale customer, so the loss or delay of a single program can swing results materially.
Both sides are worked through properly, with the high and low targets used as the bull and bear anchors, on the AEHR is it a buy page.
Your questions about Aehr Test Systems
Ask Walnut's AI anything about AEHR and see how it fits what you own.
FAQ
What is the price target for Aehr Test Systems (AEHR)?
+
The average analyst price target for AEHR is $123.75 as of November 2026, across 4 analysts. The average is +142.7% against the $50.98 share price on November 16, 2026, so the consensus sits well above where the stock trades. The median target, which is less distorted by one extreme view, is $122.50. Targets move constantly; verify the current figure before relying on it.
How high could AEHR go?
+
The highest published target is $140.00, which is +174.6% against the $50.98 price. It is one analyst's most optimistic case, not a ceiling and not a forecast. The lowest is $110.00. The gap between them answers this question best: analysts who all follow Aehr Test Systems closely disagree by 24% of the average target, so treat any single number as one scenario.
How many analysts cover AEHR?
+
4 analysts publish estimates on AEHR as of November 2026. Of those with a published rating, 5 say buy, 0 hold, and 0 sell, so 100% carry a buy rating. More coverage usually means the consensus is better informed, though it also means the obvious points are already in the price.
Are analyst price targets for AEHR accurate?
+
Treat them as informed opinion, not measurement. Two things matter here. Sell-side ratings skew positive across the market, and AEHR is no exception at 100% buy ratings, so the distribution is not a balanced vote. And targets tend to follow the share price at least as often as they lead it, getting raised after a stock has already run. They are most useful as a read on what the informed consensus expects, and least useful as a prediction of where the price lands.
Has the AEHR price target been raised or cut recently?
+
In the last six months there have been 0 raises and 2 cuts among the published actions on AEHR. The most recent was Lake Street, which lowered its target to $90.00 from $110.00 on November 3, 2026. The direction of revisions often tells you more than the level, because it shows which way the informed view is moving.
What are analysts' earnings estimates for Aehr Test Systems (AEHR)?
+
For the fiscal year ending Jun 2027, the 5 analysts publishing estimates on AEHR expect earnings of $1.00 per share (+3227% on the year before) and revenue of $150.5 million (+201%). For the fiscal year ending Jun 2028, the consensus is $1.68 per share, +69% on the year before. These are consensus estimates as of November 2026, the average of what the covering analysts publish, and they are revised constantly, especially around each earnings report. They describe expectations, not results.
When does AEHR report earnings next?
+
Aehr Test Systems's next earnings report is scheduled for November 2, 2026. The report is when the estimates on this page get tested against actual results, which is why targets and estimates tend to move most in the days after it.
What is the AEHR stock price prediction for 2030?
+
There is no published one. Analyst targets run to about twelve months and no firm covering AEHR publishes a 2030 figure, so any site showing one has extrapolated a growth rate of its own. The answerable version of the question is what the current price already assumes about Aehr Test Systems's earnings, which the forward multiple on this page sets out, and what would have to change for that to break.
Will AEHR go up in 2026?
+
Nobody knows, including the analysts publishing targets. What the numbers on this page tell you is where informed opinion currently sits and how much it disagrees with itself, which is useful and different from a prediction. The risk most often cited against Aehr Test Systems: Customer concentration is heavy: a small number of large semiconductor manufacturers drive most revenue, and the AI story leans on one lead hyperscale customer, so the loss or delay of a single program can swing results materially. Walnut is not an investment adviser.
Walnut is informational, not investment advice, and does not publish price targets of its own. The analyst figures on this page come from a November 2026 data pull of published third-party research, are approximate, and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026, and every percentage against it on this page is measured from that price. Verify current figures with your broker before acting on them.